A Study of JNJ-75220795 in Japanese Participants

NCT05039710 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

9

Enrollment

INDUSTRY

Sponsor class

Stopped Business Judgement

Conditions

Fatty Liver

Interventions

DRUG: JNJ-75220795
OTHER: Placebo

Sponsor

Janssen Pharmaceutical K.K.